As of 2024-12-11, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.33 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -100.3%.
The range of the Relative Valuation is (0.01) - (0.02) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | - | - |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -100.1% - -100.5% | -100.3% |
| Date | P/E |
| 2024-12-09 | -17.58 |
| 2024-12-06 | -17.48 |
| 2024-12-05 | -17.52 |
| 2024-12-04 | -17.58 |
| 2024-12-03 | -17.68 |
| 2024-12-02 | -17.52 |
| 2024-11-29 | -17.29 |
| 2024-11-28 | -17.12 |
| 2024-11-27 | -17.29 |
| 2024-11-26 | -17.35 |
| 2024-11-25 | -17.29 |
| 2024-11-22 | -17.35 |
| 2024-11-21 | -17.39 |
| 2024-11-20 | -17.09 |
| 2024-11-19 | -16.89 |
| 2024-11-18 | -17.62 |
| 2024-11-15 | -17.03 |
| 2024-11-14 | -17.12 |
| 2024-11-13 | -16.89 |
| 2024-11-12 | -16.76 |
| 2024-11-11 | -16.96 |
| 2024-11-08 | -17.25 |
| 2024-11-07 | -16.89 |
| 2024-11-06 | -18.83 |
| 2024-11-05 | -18.80 |
| 2024-11-04 | -18.53 |
| 2024-11-01 | -18.53 |
| 2024-10-31 | -18.50 |
| 2024-10-30 | -18.37 |
| 2024-10-29 | -18.50 |
| 2024-10-28 | -18.60 |
| 2024-10-25 | -18.21 |
| 2024-10-24 | -18.37 |
| 2024-10-23 | -18.21 |
| 2024-10-22 | -18.40 |
| 2024-10-21 | -18.40 |
| 2024-10-18 | -18.70 |
| 2024-10-17 | -18.53 |
| 2024-10-16 | -18.50 |
| 2024-10-15 | -18.57 |
| 2024-10-11 | -18.83 |
| 2024-10-10 | -18.90 |
| 2024-10-09 | -19.29 |
| 2024-10-08 | -19.35 |
| 2024-10-07 | -19.62 |
| 2024-10-04 | -18.76 |
| 2024-10-03 | -18.90 |
| 2024-10-02 | -18.90 |
| 2024-10-01 | -19.12 |
| 2024-09-30 | -19.45 |